Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Sequent Scientific Limited
SEQUENTSequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments. Address: Dosti Pinnacle, Mumbai, India, 400604
Analytics
WallStreetin tavoitehinta
11 271.84 INRP/E-suhde
1014.8572Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut SEQUENT
Osinkoanalytiikka SEQUENT
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
12 %Osinkohistoria SEQUENT
Osakkeen arvostus SEQUENT
Talousasiat SEQUENT
Tuloksia | 2019 | Dynamiikka |